Newsmeme!
Discover News you didn't know existed
FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, today announced results from its Phase 2/3 clinical trial, EmbraceAC, comparing its novel anticoagulant agent tecarfarin with the leading oral anticoagulant warfarin.
PEOPLE who travel have nearly triple the normal risk of developing a dangerous blood clot, researchers reported.
People who travel have nearly triple the normal risk of developing a dangerous blood clot, with a measurable increase for every two hours spent sitting in a car or wedged into an airline seat.
People who travel have nearly triple the normal risk of developing a dangerous blood clot, with a measurable increase for every two hours spent sitting in a car or wedged into an airline seat, researchers reported on Monday.
Treatment strategies for acute basilar artery occlusion (BAO) are based on case series and data that have been extrapolated from stroke intervention trials in other cerebrovascular territories, and information on the efficacy of different treatments in unselected patients with BAO is scarce.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |